Key Insights

Highlights

Treatment Research

11 treatments under study, led by Purge Cleaning

Research Leaders

10 sponsors active, led by University Hospital, Ghent

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 9 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

7Total
Not Applicable (1)
Phase 1 (3)
Phase 1/2 (2)
Phase 2 (1)

Trial Status

Not Yet Recruiting4
Recruiting3
Active Not Recruiting2

Clinical Trials (9)

Showing 9 of 9 trials
NCT07799974RecruitingPrimary

Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study

NCT07772895Phase 1RecruitingPrimary

Pemefolacianine for IMI of Lung Cancer

NCT07457541Phase 1Active Not RecruitingPrimary

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

NCT07638878Active Not RecruitingPrimary

The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer

NCT07583316Phase 1Not Yet RecruitingPrimary

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

NCT07461662Not ApplicableNot Yet RecruitingPrimary

Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination

NCT07303881Phase 2Not Yet Recruiting

Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

NCT03556228Phase 1/2Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT07260058Phase 1/2Not Yet RecruitingPrimary

Immune Cell Therapy for Advanced Solid Tumors

Showing all 9 trials

Research Network

Common Treatments

  • Purge Cleaning1
  • Tislelizumab In Combination With Nabpaclitaxel And Platinum Chemotherapy1
  • Pemefolacianin Cohort 2 In Part B1
  • Autologous Immune Cells1
  • Crpa1a21

Active Sponsors

  • University Hospital, Ghent1
  • VM Oncology, LLC1
  • Guangzhou Medical University1
  • Liaoning Cancer Hospital & Institute1
  • Tomsk National Research Medical Center of the Russian Academy of Sciences1

Top Investigators

Related Conditions

  • Colorectal Cancer Locally Advanced Or Metastatic2
  • Breast Cancer Locally Advanced Or Metastatic2
  • Advanced Solid Tumors1
  • Irae1
  • Esophageal Cancer1

Activity Timeline